Trial intelligence / Profile preview

Cambia PK and Safety in Pediatric Migraine

NCT02287376Phase 4Completed

Sponsor
Assertio
Start
Jan 2015
Primary completion
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of diclofenac in migraine, sponsored by Assertio. Started Jan 2015; status: completed.

02

Drugs

diclofenac
03

Conditions

migraine

Beyond the preview

Go deeper on NCT02287376.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02287376.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call